In a statement Japanese drug maker Shionogi & Co Ltd said, their experimental treatment for COVID-19 has shown rapid clearance of the virus that causes the disease. The pill, S-217622, “demonstrated rapid clearance of the infectious SARS-CoV-2 virus”, said Shionogi… Read More ›
drug maker
Novartis faces shareholder ire at AGM over skyrocketing drug prices
Shareholders are scheduled to vote on Novartis’s planned spin-off of its Alcon eye care unit. On Thursday, at the annual general meeting of Swiss drugmaker Novartis, shareholders came in heavily at the drugmaker for the hike in drug prices. Novartis… Read More ›